Frohlich Mark W
SEC insider (Form 3/4/5 filer). CIK 0001420482. Director at RIGEL PHARMACEUTICALS INC (RIGL). 3 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Frohlich Mark W has filed insider reports for
- RIGEL PHARMACEUTICALS INC (RIGL): Director
Frohlich Mark W
CIK: 0001420482
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RIGL
RIGEL PHARMACEUTICALS INC
Director